Inflammatory mediators, cytokines, and endotoxins

Inflammatory mediators, cytokines, and endotoxins constitute a heterogeneous group of molecules that orchestrate the complex biological response to harmful stimuli, such as pathogens or tissue damage. Cytokines, including interleukins (IL) and tumor necrosis factors (TNF), are pivotal signaling proteins that regulate the intensity and duration of the immune response (StatPearls, 2023: https://www.ncbi.nlm.nih.gov/books/NBK542220/). Endotoxins, specifically lipopolysaccharides (LPS) from Gram-negative bacteria, act as potent exogenous triggers that activate innate immunity by binding to pattern recognition receptors like Toll-like receptor 4 (TLR4) (NIH, 2022: https://www.ncbi.nlm.nih.gov/books/NBK554507/). These mediators facilitate the recruitment of immune cells, alter vascular permeability, and induce systemic effects like fever. Dysregulation of these pathways is a primary driver of pathological states such as sepsis, rheumatoid arthritis, and cytokine release syndrome (PubMed, 2020: https://pubmed.ncbi.nlm.nih.gov/32602730/). Therapeutic strategies aimed at this group involve the use of monoclonal antibodies to neutralize specific cytokines or the administration of receptor antagonists to prevent downstream signaling.

Other names

Pro-inflammatory mediatorsInflammatory signaling moleculesPyrogensInflammatory factorsInflammatory secretome

Therapeutic agents targeting these entities typically function by neutralizing circulating ligands (e.g., monoclonal antibodies), blocking their cognate receptors (e.g., receptor antagonists), or inhibiting the intracellular signaling cascades they initiate (e.g., JAK inhibitors).